Autres langues 180 Life Sciences Corp.

Actions

KBLM

US68236V3024

Temps Différé Nasdaq Autres places de cotation 18:32:58 29/04/2024			Varia. 5j.	Varia. 1 janv.
1,93 ^USD	+7,22%		+7,22%	-52,42%

25/03	180 Life Sciences Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
11/03	180 Life Sciences Corp. annonce des changements au sein de son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
180 Life Sciences : Corporate Presentation	15/03
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	14/03
180 Life Sciences Corp. Announces Board Changes	11/03
180 Life Sciences Corp. Appoints Blair Jordan as A Member of the Board of Directors	29/02
180 Life Sciences to Conduct 1-For-19 Reverse Stock Split	26/02
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan	26/02
180 Life Sciences Corp. announced a financing transaction	21/02
180 Life Sciences Corp. Announces Board Resignations	21/12
180 Life Sciences Corp. Announces Resignation of Donald A. Mcgovern, as Member of the Board of Directors	20/12
180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternatives	04/12
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04/12
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04/12
180 Life Sciences : Material Agreement - Form 8-K	29/11
180 Life Sciences Announces Review of Strategic Alternatives	28/11
180 Life Sciences Announces Review of Strategic Alternatives	28/11
Certain Warrants of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
Certain Stock Options of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
Certain Common Stock of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 180 Life Sciences Corp.

Actions

KBLM

US68236V3024

Autres langues

Filtres